Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry

Overview

Journal Mar Drugs

Publisher MDPI

Specialties Biology
Pharmacology

Date 2015 Oct 30

PMID 26512677

Citations 17

Authors

Yiping Zhang

Hao Wu

Hongmei Wen

Hua Fang

Zhuan Hong

Ruizao Yi

Rui Liu

Affiliations

Soon will be listed here.

Abstract

Fucoxanthin and its deacetylated metabolite fucoxanthinol are two major carotenoids that have been confirmed to possess various pharmacological properties. In the present study, fucoxanthinol was identified as the deacetylated metabolite of fucoxanthin, after intravenous (i.v.) and intragastric gavage (i.g.) administration to rats at doses of 2 and 65 mg/kg, respectively, by liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis. Next, an accurate and precise LC-MS/MS method was developed to quantitatively determine fucoxanthin and fucoxanthinol in rat plasma. Plasma samples were resolved by LC-MS/MS on a reverse-phase SB-C18 column that was equilibrated and eluted with acetonitrile (A)/aqueous 0.1% formic acid (B; 92/8, v/v) at a flow rate of 0.5 mL/min. Analytes were monitored by multiple-reaction monitoring (MRM) under positive electrospray ionization mode. The precursor/product transitions (m/z) were 659.3→109.0 for fucoxanthin, 617.2→109.0 for fucoxanthinol, and 429.4→313.2 for the internal standard (IS). Calibration curves for fucoxanthin and fucoxanthinol were linear over concentrations ranging from 1.53 to 720 and 1.17 to 600 ng/mL, respectively. The inter- and intraday accuracy and precision were within ±15%. The method was applied successfully in a pharmacokinetic study and the resulting oral fucoxanthin bioavailability calculated.

Citing Articles

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Flieger J, Forma A, Flieger W, Flieger M, Gawlik P, Dzierzynski E Int J Mol Sci. 2024; 25(16).

PMID: 39201668 PMC: 11354426. DOI: 10.3390/ijms25168982.

Antioxidant and Neuroprotective Effects of Fucoxanthin and Its Metabolite Fucoxanthinol: A Comparative In Vitro Study.

Pruccoli L, Balducci M, Pagliarani B, Tarozzi A Curr Issues Mol Biol. 2024; 46(6):5984-5998.

PMID: 38921028 PMC: 11202671. DOI: 10.3390/cimb46060357.

Pharmacokinetic Analysis of Zonarol, a Marine Algal Hydroquinone, in Mice Using HPLC with Fluorescence Detection.

Fei J, Yamada S, Satoh T, Koyama T Antibiotics (Basel). 2023; 12(6).

PMID: 37370332 PMC: 10295794. DOI: 10.3390/antibiotics12061013.

Advances in Fucoxanthin Research for the Prevention and Treatment of Inflammation-Related Diseases.

Guan B, Chen K, Tong Z, Chen L, Chen Q, Su J Nutrients. 2022; 14(22).

PMID: 36432455 PMC: 9694790. DOI: 10.3390/nu14224768.

Inhibitory Potential of Six Brown Algae from the Persian Gulf on α-Glucosidase and Antidiabetic Effect of .

Moheimanian N, Mirkhani H, Sohrabipour J, Jassbi A Iran J Med Sci. 2022; 47(5):484-493.

PMID: 36117578 PMC: 9445867. DOI: 10.30476/IJMS.2021.91258.2245.

References

Sugawara T, Baskaran V, Tsuzuki W, Nagao A . Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. J Nutr. 2002; 132(5):946-51. DOI: 10.1093/jn/132.5.946. View

Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H . Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol. 2002; 65(2):173-9. DOI: 10.1016/s0006-2952(02)01478-8. View

Konishi I, Hosokawa M, Sashima T, Kobayashi H, Miyashita K . Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Comp Biochem Physiol C Toxicol Pharmacol. 2005; 142(1-2):53-9. DOI: 10.1016/j.cbpc.2005.10.005. View

Das S, Hashimoto T, Shimizu K, Yoshida T, Sakai T, Sowa Y . Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Biochim Biophys Acta. 2005; 1726(3):328-35. DOI: 10.1016/j.bbagen.2005.09.007. View

Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K . Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Biochim Biophys Acta. 2004; 1675(1-3):113-9. DOI: 10.1016/j.bbagen.2004.08.012. View

Asai A, Sugawara T, Ono H, Nagao A . Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites. Drug Metab Dispos. 2004; 32(2):205-11. DOI: 10.1124/dmd.32.2.205. View

Maeda H, Hosokawa M, Sashima T, Takahashi N, Kawada T, Miyashita K . Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int J Mol Med. 2006; 18(1):147-52. View

Yang K, Lin L, Tseng T, Wang S, Tsai T . Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 853(1-2):183-9. DOI: 10.1016/j.jchromb.2007.03.010. View

Maeda H, Hosokawa M, Sashima T, Miyashita K . Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J Agric Food Chem. 2007; 55(19):7701-6. DOI: 10.1021/jf071569n. View

10.

Dembitsky V, Maoka T . Allenic and cumulenic lipids. Prog Lipid Res. 2007; 46(6):328-75. DOI: 10.1016/j.plipres.2007.07.001. View

11.

Sachindra N, Sato E, Maeda H, Hosokawa M, Niwano Y, Kohno M . Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J Agric Food Chem. 2007; 55(21):8516-22. DOI: 10.1021/jf071848a. View

12.

Ishikawa C, Tafuku S, Kadekaru T, Sawada S, Tomita M, Okudaira T . Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Int J Cancer. 2008; 123(11):2702-12. DOI: 10.1002/ijc.23860. View

13.

Heo S, Jeon Y . Protective effect of fucoxanthin isolated from Sargassum siliquastrum on UV-B induced cell damage. J Photochem Photobiol B. 2009; 95(2):101-7. DOI: 10.1016/j.jphotobiol.2008.11.011. View

14.

Hashimoto T, Ozaki Y, Taminato M, Das S, Mizuno M, Yoshimura K . The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. Br J Nutr. 2009; 102(2):242-8. DOI: 10.1017/S0007114508199007. View

15.

Woo M, Jeon S, Kim H, Lee M, Shin S, Shin Y . Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice. Chem Biol Interact. 2010; 186(3):316-22. DOI: 10.1016/j.cbi.2010.05.006. View

16.

Heo S, Yoon W, Kim K, Ahn G, Kang S, Kang D . Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food Chem Toxicol. 2010; 48(8-9):2045-51. DOI: 10.1016/j.fct.2010.05.003. View

17.

Urikura I, Sugawara T, Hirata T . Protective effect of Fucoxanthin against UVB-induced skin photoaging in hairless mice. Biosci Biotechnol Biochem. 2011; 75(4):757-60. DOI: 10.1271/bbb.110040. View

18.

Park H, Lee M, Park Y, Shin Y, Choi M . Beneficial effects of Undaria pinnatifida ethanol extract on diet-induced-insulin resistance in C57BL/6J mice. Food Chem Toxicol. 2010; 49(4):727-33. DOI: 10.1016/j.fct.2010.11.032. View

19.

Yamamoto K, Ishikawa C, Katano H, Yasumoto T, Mori N . Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas. Cancer Lett. 2010; 300(2):225-34. DOI: 10.1016/j.canlet.2010.10.016. View

20.

Kim K, Heo S, Kang S, Ahn G, Jeon Y . Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicol In Vitro. 2010; 24(6):1648-54. DOI: 10.1016/j.tiv.2010.05.023. View